Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on April 21, 2026

Apr. 21, 2026

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 21, 2026

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

Indeterminate GlobeNewswire

Apr. 21, 2026

Oculis Publishes Invitation to the Annual General Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

TELA Bio to Announce First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 21, 2026

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Apr. 21, 2026

Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

PharmAla Issues Q2 Financial Statements and Grants Options

Indeterminate GlobeNewswire

Apr. 21, 2026

Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

Indeterminate GlobeNewswire

Apr. 21, 2026

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States

Indeterminate GlobeNewswire

Apr. 21, 2026

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

Indeterminate GlobeNewswire

Apr. 21, 2026

Cytokinetics to Announce First Quarter Results on May 5, 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Neuro Salt Ingredients Decoded: Deciphering the Difference Between Official Website Hype & Actual Health Benefits

Indeterminate GlobeNewswire